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Akt1 Controls Insulin-Driven VEGF Biosynthesis
from Keratinocytes: Implications for Normal and
Diabetes-Impaired Skin Repair in Mice
Itamar Goren1,3, Elke Mu¨ller1,3, Dana Schiefelbein1, Paul Gutwein1, Oliver Seitz2, Josef Pfeilschifter1 and
Stefan Frank1
Here we investigated the potential role of protein kinase B (Akt) in normal or diabetes-impaired wound healing
in mice. Interestingly, Akt1 was predominant in skin, wound tissue, and human keratinocytes cell line. Acute
skin repair was characterized by an increase of Akt1 phosphorylation in wound margin keratinocytes. By
contrast, phosphorylated Akt1 was nearly completely absent and paralleled by a poor phosphorylation of the
eucaryotic initiation factor 4E-binding protein 1 (4E-BP1) and reduced levels of vascular endothelial growth
factor (VEGF) protein in chronic wounds of diabetic ob/ob mice. Inhibition of the phosphatidyl-inositol-3
kinase/Akt pathway by wortmannin and specific abrogation of Akt1 protein using small-interfering RNA
revealed a regulatory function of Akt1 in insulin-mediated VEGF biosynthesis in keratinocytes. Insulin-induced
VEGF protein biosynthesis in keratinocytes was mediated by Akt1 from a constitutive VEGF-encoding mRNA
pool at the posttranscriptional level through a downstream phosphorylation 4E-BP1. Moreover, transfection
experiments introducing a constitutively active mutant of Akt1 into keratinocytes revealed the mammalian
target of rapamycin kinase as a downstream mediator of Akt1-linked 4E-BP1 phosphorylation and translational
control. Our data suggest that the endocrine hormone insulin contributes to VEGF release in skin wounds
through an Akt1-mediated posttranscriptional mechanism in keratinocytes.
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INTRODUCTION
Wound healing of the skin represents the highly coordinated
response of an organism to deal with external injuries
(Martin, 1997; Singer and Clark, 1999). However, there are
a number of well-described pathological conditions that
severely interfere with a successful wound closure. Among
those, the diabetic foot ulcer represents a serious wound
healing complication that is characterized by a loss of
epithelium and dermis that may sometimes also involve
muscle and bone (Reiber and Ledoux, 2002; Boulton, 2004).
Unfortunately, foot ulcers of both types of diabetes mellitus
are associated with a significant mortality (Carrington et al.,
2001; Reiber and Ledoux, 2002). Diabetic ulcers still have a
poor prognosis with assessed 3-year survival rates of only
about 50% in developed European countries (Apelqvist et al.,
1993; Faglia et al., 2001).
Obviously, diabetes-disturbed wound healing must be
functionally connected to prolonged and exacerbated in-
flammatory conditions in genetically diabetic mice (Wetzler
et al., 2000; Goren et al., 2003, 2006) and also in man (Loots
et al., 1998). Interestingly, resolution of exacerbated inflam-
matory conditions in wound tissue from ob/ob mice by
recombinant leptin or antibody-mediated inactivation of
wound macrophages (Goren et al., 2006, 2007) demon-
strated that a severe insulin resistance of resident wound cells
contributes to disturbed tissue movements in chronic wounds
of diabetic mice. Moreover, these findings strongly suggest
that insulin, beside its well-known glucose-controlling endo-
crine functions, participates in tissue repair by activation of
the insulin signaling pathway in wound tissue (Goren et al.,
2006). This notion is further supported by findings that report
a function of insulin and insulin-like growth factor 1 in the
expressional control of the angiogenetic factor vascular
endothelial growth factor (VEGF) via activation of the
phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt)
in diverse cell types including epithelial cells (Treins et al.,
2002; Jiang et al., 2003; Poulaki et al., 2003; He et al., 2006).
To date, only little is known about a potential role of
insulin itself in diabetes-impaired wound tissue and also
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intracellular signaling processes that drive and integrate
insulin, cytokine- or growth factor-mediated cellular deci-
sions at the wound site. One key molecule of the insulin
signaling pathway at the crossroads from activated cytokine
and growth factor receptors is Akt (Plas and Thompson,
2005), representing three highly conserved isoforms: Akt1,
Akt2, and Akt3 (Testa and Tsichlis, 2005) and a target of
active PI3K (Franke et al., 1995). The subsequent enzymatic
activation of Akt is mediated by phosphatidylinositol-
dependent kinase (PDK)-1 and the mammalian target of
rapamycin (mTOR)/rapamycin-insensitive companion of
mTOR through phosphorylation of Akt in its activation loop
(Thr308) and C-terminal tail (Ser473), respectively (Sarbassov
et al., 2005).
Here, we determined Akt1 to represent the predominant
isoform in murine wound healing and in the human
keratinocyte cell line (HaCaT). Phosphorylated Akt1 was
present in wound margin keratinocytes during acute skin
repair, but appeared markedly reduced in diabetes-impaired
wound tissue. We observed that only insulin-, but not
cytokine or growth factor-induced VEGF production was
restrictively dependent on Akt activation in keratinocytes.
RESULTS
Akt expression and phosphorylation in skin and wound tissue
of healthy and insulin-resistant diabetic ob/ob mice
First, we investigated the expression and phosphorylation of
the Akt 1–3 isoforms during acute and diabetes-disturbed skin
repair in diabetic ob/ob mice. We observed a moderate
increase of mRNAs encoding Akt1 and Akt3 during the
inflammatory phase of normal repair (Figure 1a). All three Akt
isoforms were present at the protein level in acute healing,
with particularly low levels of Akt3 in immunoblot analyses
(Figure 1b, see also Figure 4c). However, we observed a
marked increase in total Akt phosphorylation at residues
Ser473 and Thr308 during repair, which is described to be
pivotal for Akt enzymatic activation (Sarbassov et al., 2005).
Akt phosphorylation was paralleled by a subsequent phos-
phorylation of glycogen synthase kinase (GSK)-3a/b (Ser21/9;
Figure 1b) and eucaryotic initiation factor 4E-binding protein
1 (4E-BP1; Figure 5c) that are both described to represent
targets for Akt enzymatic activity (Cross et al., 1995; Segrelles
et al., 2004). By contrast, disturbed wound tissue of diabetic
ob/ob mice was characterized by reduced levels of Akt1 and
a nearly complete absence of Akt2 and Akt3 protein
compared to healing conditions in healthy animals (Figure
2b, left panels). By contrast, wound tissue mRNA pools for
Akt1 were not reduced in diabetic ob/ob mice (Figure 2a),
indicating that the observed loss of Akt1 protein (Figure 2b)
was not a consequence of impaired Akt1 mRNA synthesis.
Moreover, the marked phosphorylation of Akt at either
Thr308 or Ser473 residues as well as the subsequent
phosphorylation of GSK-3a/b was absent in wound tissue of
diabetic ob/ob mice (Figure 2b, right panels). The absence of
a marked phosphorylation of Akt in diabetes-impaired wound
tissue was confirmed by direct quantification of phosphory-
lated Akt by enzyme-linked immunosorbent assay at day 5
(Figure 2c, left panel) and by immunoblot analyses at day 13
post-wounding (Figure 2c, right panel). Here, it is important
to note that the reduction in phosphorylated Akt in wound
tissue appeared to depend at least partially on the availability
of total Akt protein also, which was reduced in 5- and 13-day
wounds of ob/ob mice (Figure 2c).
Using immunohistochemistry, we determined the locali-
zation of activated Akt during acute skin repair. Keratinocytes
located at the margins of the wound exhibited particularly
strong signals for phosphorylated Akt (Ser473, Thr308) and
GSK-3a/b (Ser21/9; Figure 3). A histology to control
specificity of the phosphorylated Akt antibodies is shown in
Figure S1.
As a next step, we separated 5-day wound tissue of normal
mice into wound margin (enriched for the proliferative
wound margin keratinocytes) and inner wound (including
the granulation tissue) sections (Figure 4a, left panel) and
nonwounded tail skin into epidermis and dermis (Figure 4a,
right panel) to allow a more detailed analysis. Epidermal–-
dermal separation was controlled using loricrin as a specific
keratinocyte expression marker (Figure 4a, right panel). The
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Figure 1. Expression and phosphorylation of Akt in normal skin repair.
Regulation of Akt isoform mRNA (a) and protein (b) expression (left panels) or
phosphorylation (right panels) in C57BL/6 mice as assessed using the RNase
protection assay or immunoblot. The time after injury is indicated at the top of
each lane. Ctrl skin refers to back skin biopsies of nonwounded mice.
1,000 c.p.m. of the hybridization probe were added to the lane-labeled probe.
Hybridization against GAPDH was used as a loading control. A lysate of
insulin-stimulated murine primary keratinocytes (mKC, Ins) was used to
provide specificity of anti-Akt antibodies. A quantification of Akt1, Akt2, and
Akt3 mRNA (PhosphoImager PSL counts per 10 mg of total wound RNA) is
shown in the left panel. *, Po0.05; NS, not significant (ANOVA, Dunnett’s
method) as compared to control skin. Bars indicate the mean±SD obtained
from wounds (n¼ 48) isolated from animals (n¼12) from three independent
animal experiments. For immunoblot analysis, each time point depicts eight
wounds (n¼8) from four individual mice (n¼ 4). One representative blot
from three independent experimental animal series is shown. Loading of
immunoblots was controlled using a total Akt or Ponceau S staining as
indicated. d, days.
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appearance of phosphorylated Akt protein in wound margin
keratinocytes was supported by an induction of Akt1- and
Akt2-specific mRNA species at the wound margins. Although
Akt1-3-specific mRNAs were constitutively expressed in the
dermis of nonwounded skin, isolation of wound margin tissue
from day 5 post-wounding (which contained the enriched
keratinocyte fraction of the developing wound margin
epithelia) revealed particularly strong signals for Akt1 and,
to a lesser extent, for Akt-2 mRNA (Figure 4b), suggesting an
induction of Akt1 mRNA expression in wound keratinocytes.
Although the S473 and T308 phospho-specific antibodies
that had been used for immunoblot and histologic analyses
have been generated against the Akt1 phospho-motifs, we
could not absolutely differentiate for active Akt1 using these
antibodies. Therefore, we now determined the predominant
Akt isoform in skin and wound tissue as well as in cultured
keratinocytes. To this end, we performed immunoprecipita-
tion experiments using Akt1, -2, or -3-specific antisera.
Results from the first set of experiments revealed Akt1 as the
predominant isoform in normal and wounded skin tissue
(Figure 4c). In addition, we performed immunoblots to detect
the respective Akt protein isoforms directly from total cellular
protein lysates of HaCaT. For this purpose, we separated two
individual lanes each (IB no. 1, 2) of the filter after blotting
and incubated the individual filter lanes with the respective
anti-Akt1, -Akt2, or -Akt-3 antibodies as indicated. Incuba-
tion against a total Akt-specific antibody was used to control
equal loading (lower panel). The filter sections were
simultaneously exposed to the same film and exhibited
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Figure 2. Expression and phosphorylation of Akt in diabetes-impaired skin
repair. (a) RNase protection assay demonstrating Akt1 mRNA expression in
nonwounded (ctrl skin) and wounded (wd) skin of healthy (wt) and diabetic
ob/ob (ob) mice. 1,000 c.p.m. of the hybridization probe were added to the
lane-labeled probe. Hybridization against GAPDH was used as a loading
control. Every single data point depicts the mRNA isolated from four wounds
(n¼4). (b) Regulation of Akt protein expression (left panels) or
phosphorylation (right panels) in diabetic ob/ob mice. The time after injury is
indicated at the top of each lane. Ctrl skin refers to back skin biopsies of
nonwounded mice. At 7- and 13-day (d) wd lysates from C57BL/6J mice
(7-day wd wt, 13-day wd wt) were used to allow a direct comparison of pAkt
expression levels. For immunoblot analysis, each time point depicts eight
wounds (n¼8) from four individual mice (n¼ 4). One representative blot
from three independent experimental animal series is shown. Loading of
immunoblots was controlled using Ponceau S staining. (c) ELISA analyses
from lysates of 5-day wd tissue isolated from wt (C57) and diabetic ob/ob
mice. Phosphorylated (Ser473) Akt protein is expressed as units per 200 mg of
total wd protein. **, Po0.01 (unpaired Student’s t-test) as compared to
control mice (C57). Bars indicate the mean±SD obtained from wd lysates
from four individual mice (n¼4). The presence of total Akt protein from
lysates of 5-day wd tissue from wt (C57) and diabetic ob/ob mice was
analyzed below (1–3¼ individual animals). (d) Immunoblot demonstrating the
presence of phosphorylated and total Akt protein in 13-day wd lysates from
healthy (C57) and diabetic (ob/ob) mice as indicated. Every single data point
depicts two wounds from an individual animal. Loading of immunoblots was
controlled using a Ponceau S staining.
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Figure 3. Localization of Akt in regenerating skin. Frozen serial sections from
mouse wounds (days 3 and 5 (d) post-wounding) were incubated with
polyclonal rabbit antisera directed against phosphorylated Akt (Ser473 or
Thr308) or GSK-3a/b (Ser21/9) as indicated. All sections were stained with the
avidin–biotin–peroxidase complex system using 3,3-diaminobenzidine-
tetrahydrochloride as a chromogenic substrate. Nuclei were counterstained
with hematoxylin. gt, granulation tissue; he, hyperproliferative epithelium,
sc, scab. Bars, 50 mm.
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Akt1 as the major Akt isoform also in cultured human HaCaT
(Figure 4d). Here it is important to note that transfection of
HaCaT with an Akt1-specific small-interfering RNA (siRNA)
again clearly confirmed the predominance of Akt1 protein in
the cells. The completely abrogated signal for Akt1 upon Akt1
siRNA treatment of the cells was paralleled by a weak
persisting signal in the total Akt control blot in lysates from
siRNA-treated cells, unequivocally indicating the low ex-
pression level of Akt2 protein in HaCaT and also specificity of
the Akt1 siRNA knockdown approach (Figure 8a).
Insulin-mediated VEGF synthesis in keratinocytes is
controlled by a PI3K/Akt-dependent posttranscriptional reg-
ulatory mechanism. Wound margin keratinocytes are a
major source of wound-derived VEGF (Brown et al., 1992;
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Figure 5. Reduced VEGF levels and 4E-BP1 phosphorylation in diabetes-impaired wound tissue. (a) Frozen sections from a mouse 5-day wound were
incubated with a polyclonal rabbit antiserum directed against murine VEGF. Sections were stained with the avidin–biotin–peroxidase complex system using
3,3-diaminobenzidine-tetrahydrochloride as a chromogenic substrate. Nuclei were counterstained with hematoxylin. gt, granulation tissue; he,
hyperproliferative epithelium. Bar, 25mm. (b) VEGF ELISA analyses from lysates of nonwounded skin (ctrl) and lysates of wound tissue isolated from wild-type
(C57BL/6J) and diabetic ob/ob mice. VEGF protein is expressed as pg per 50mg skin or wound lysate. **, P o 0.01; *, Po0.05; NS, not significant (unpaired
Student’s t-test). Bars indicate the mean±SD obtained from wound lysates from 12 individual mice (n¼ 12). (c, d) Total protein (50 mg) from lysates of
nonwounded skin (ctrl skin) and wound tissue (days 1, 3, 5, 7, and 13 after injury as indicated) isolated from wild-type (C57BL/6J) and ob/ob mice was analyzed
by immunoblot for the presence of phosphorylated 4E-BP1 (p-4E-BP1). Expression of total 4E-BP1 was determined in (d, lower panel). Loading of immunoblots
was controlled using a Ponceau S staining.
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Figure 4. Isoform expression of Akt in regenerating skin. (a) Overview to show tissue sampling for inner wound and wound margin compartments
(left panel). RNase protection assay demonstrating the distribution of epithelial-derived loricrin mRNA to control for separation of epidermis and dermis
in tail skin tissue. Hybridization probe (1,000 c.p.m.) were added to the lane-labeled probe. Hybridization against GAPDH was used as a loading control.
(b) RNase protection assay demonstrating distribution in expression of Akt1, Akt2, and Akt3 mRNA in epidermis and dermis of nonwounded skin or at the
wound margin and inner wound (granulation tissue) on day 5 after injury as indicated. Every single data point depicts material isolated from four individual
mice (n¼ 4). Hybridization against GAPDH was used as a loading control. (c) Total protein (100mg) from nonwounded skin (skin) or 5 day wounds were
immunoprecipitated using Akt1-, Akt2, and Akt3-specific antibodies. Immunoprecipitates were analyzed by immunoblot and a total-Akt-specific antibody.
Wound lysates were obtained from eight wounds (n¼8) isolated from four individual mice (n¼4) that have been pooled before analysis. (d) Total cellular
protein (50 mg) from unstimulated HaCaT was analyzed for the presence of Akt1, Akt2, and Akt3 by immunoblot using Akt1-, Akt2-, or Akt3-specific
antibodies as indicated. Staining of total Akt served as a loading control.
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Figure 5a) that was colocalized with activated Akt1 (Figure 3,
see also Figure 11c, right panels) and markedly reduced in
acute wounds of diabetic ob/ob mice during the acute phase
of repair (Figure 5b, see also Figure 11b). The eucaryotic
initiation factor 4E-BP1 represents a prominent target of the
PI3K/Akt/mTOR pathway and has been shown to control
VEGF production from keratinocytes (Gingras et al., 2001;
Segrelles et al., 2004). Here we observed a clear loss of
phosphorylated 4E-BP1 under conditions of diabetes-dis-
turbed healing and reduced VEGF biosynthesis (Figure 5b–d).
Comparable to conditions of Akt expression and phosphor-
ylation in wound tissue (Figures 1 and 2), phosphorylated 4E-
BP1 again reflected wound expression levels of total 4E-BP1
in normal and impaired wounds (Figure 5d).
Next, we investigated a functional connection between
phosphorylated Akt and 4E-BP1 in the control of VEGF
biosynthesis by wound-derived mediators in cultured kerati-
nocytes. For this purpose, we stimulated quiescent cultured
human HaCaT with epidermal growth factor (EGF), a
combination of cytokines (IL-1b, tumor necrosis factor-a,
IFN-g) or insulin. As shown in Figure 6a–c, all applied stimuli
mediated a rapid and robust phosphorylation of Akt in the
cells (left panels), followed by large amounts of secreted
VEGF protein (right panels). The inhibitor U0126 revealed a
prominent role for p42/44 MAPK in EGF-, cytokine-, and
insulin-mediated VEGF production, whereas effects of
SB203580-inhibited p38 MAPK on VEGF synthesis were only
moderate (for EGF and cytokines) or even absent (for insulin;
Figure 6a–c, right panels).
Wortmannin potently inhibited EGF-, cytokine-, and
insulin-stimulated Akt phosphorylation in the cells (Figure
6d), but it is important to note that inhibition of the PI3K/Akt
pathway restrictively suppressed only insulin-stimulated
VEGF expression from keratinocytes (Figure 6a–c, right
panels). An overview over EGF-, cytokine-, and insulin-
mediated VEGF mRNA expression in the presence or absence
of U0126 or SB203580 (mRNA data to Figure 6a–c) is given
in Figure S2. By contrast to EGF and cytokine treatments,
insulin did not increase VEGF mRNA in the presence or
absence of wortmannin (Figure 7a), suggesting a posttran-
scriptional mechanism of insulin action. In accordance, only
insulin-mediated phosphorylation of 4E-BP1 became reduced
upon wortmannin after 4 and 8 hours, but notably remained
unaffected in EGF- and cytokine-stimulated keratinocytes
(Figure 7b) at these time points. Phosphorylation of 4E-BP1 at
the control time point (00), which reflected quiescent
keratinocytes pretreated by wortmannin for 30minutes before
the addition of stimuli, suggested that the observed constitu-
tive phosphorylation of 4E-BP1 was dependent on a basal
PI3K activity. In line with published data, rapamycin, added
to interfere with 4E-BP1 phosphorylation downstream of
Akt1, blunted 4E-BP1 phosphorylation, and subsequent
production of VEGF in insulin-treated keratinocytes (Figure
7c). We did not consider p70S6 kinase for an additional
analysis, as phosphorylation of p70S6 kinase has been shown
to be not impaired in Akt1/2 double-knockout mice (Peng
et al., 2003).
Specific abrogation of Akt1 protein by siRNA completely
abolishes insulin-induced VEGF biosynthesis in keratinocytes
Inhibition of the PI3K/Akt signaling pathway by wortmannin
had shown a dramatic reduction in insulin-induced VEGF
production from HaCaT (Figure 6c). To unequivocally prove
the functional contribution of the Akt1 isoform in this
process, we depleted functional Akt1 protein from the cells
using an Akt1-specific siRNA approach. As shown in
Akt
pAkt (T308)
pAkt (S473)
WTM+++++++
60 kDa
60 kDa
0′
ctrl
10′
EGF
10′
Cytmix
10′
Ins
30′
EGF
30′
Cytmix
30′
Ins
Ins
Ins
WTM U0126 SB
**
*
NS
1,500
1,000
500
VE
G
F 
pr
ot
ei
n
(24
 ho
urs
) (
pg
 m
l–1
)
Akt
Akt (T308)
pAkt (S473)
60 kDa
60 kDa
60 kDa
60 kDa
60 kDa
60 kDa
60 kDa
60 kDa
60 kDa
80
′ 
ctr
l
80
′ 
ctr
l
80
′ 
ctr
l
0′ 
ctr
l
80
′ 
EG
F
40
′ 
EG
F
10
′ 
EG
F
5′ 
EG
F
0′ 
ctr
l
80
′ 
Cy
tm
ix
40
′ 
Cy
tm
ix
10
′ 
Cy
tm
ix
5′ 
Cy
tm
ix
80
′ 
Ins
40
′ 
Ins
10
′ 
Ins
5′ 
Ins
0′ 
ctr
l
Akt
pAkt (T308) 
pAkt (S473)
**
**
*
Cytmix
Cytmix
WTM U0126 SB
1,000
2,000
3,000
4,000
VE
G
F 
pr
ot
ei
n
(24
 ho
urs
) (
pg
 m
l–1
)
VE
G
F 
pr
ot
ei
n
(24
 ho
urs
) (
pg
 m
l–1
)
EGF WTMU0126 SB
EGF
**
*
NS
6,000
4,000
2,000
Akt
pAkt (T308)
pAkt (S473)
Figure 6. EGF-, cytokine-, and insulin-mediated Akt activation and VEGF
production in cultured keratinocytes. Total cellular protein or cell culture
supernatants from EGF- (a), cytokine (IL-1b, TNF-a, IFN-g) (b), and insulin-
(c) stimulated HaCaT were analyzed for either presence of Thr308- and
Ser473-phosphorylated Akt protein at the indicated time points by
immunoblot (upper panels) or for VEGF protein release by ELISA after
24 hours of stimulation in the presence or absence of the indicated protein
kinase inhibitors (WTM, wortmannin; U0126; SB203580) (lower panels).
Loading of immunoblot was controlled by analysis of total Akt protein. VEGF
protein is expressed as pg per ml supernatant. **, Po0.01; *, Po0.05; NS, not
significant (unpaired Student’s t-test) as compared to stimulated
(EGF, cytomix, insulin) conditions. Bars indicate the mean±SD obtained from
supernatants from three independent cell culture experiments (n¼ 3).
(d) Immunoblot for Thr308- and Ser473-phosphorylated Akt protein from
EGF-, cytokine (IL-1b, TNF-a, IFN-g) and insulin-stimulated HaCaT to control
the inhibitory effect of wortmannin (WTM) on Akt phosphorylation.
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Figure 8a (upper panel), Akt1 siRNA transfection potently
abrogated Akt1 protein from keratinocytes. Moreover, the
nearly complete loss of the total Akt protein signal (lower
panel) upon Akt1 siRNA treatment clearly revealed Akt1 as
the dominant Akt isoform in the cells. Importantly, the
remaining weak signal for total Akt in parallel to the Akt1
siRNA knockdown again reflects not only the low expression
level of Akt2 in keratinocytes (Figure 4d), but also Akt1 siRNA
specificity, which is confirmed in addition by analysis of
lysates using an Akt2-specific antibody (middle panel). As
shown in Figure 4d, Akt 3 was not expressed and thus could
not be assessed for expression in this particular experiment.
In accordance to the inhibitor studies, we observed a
complete dependence of insulin-induced VEGF protein
biosynthesis on the presence of a functional Akt1 protein in
keratinocytes (Figure 8b).
Constitutively active Akt1 confers an increase in keratinocyte
VEGF production and drives phosphorylation of 4E-BP1 via
activation of mTOR
To further scrutinize a regulatory role of activated Akt1 in
keratinocyte VEGF production, we generated a myristoylated
and thus constitutively active Akt1-Flag protein (Andjelkovic
et al., 1997; myrAkt1). Wild-type Akt1-Flag and an inactive
Akt1-Flag mutant protein in which we had replaced Thr308
and Ser473 residues by Ala (Akt1-TASA) served as controls.
Restricted localization of myrAkt1, but not of wild-type Akt1
and Akt1-TASA, at the plasma membrane suggested an active
myrAkt1 in transfected cells (Figure 9a, lower panels). As
HaCaT were hard to transfect, we controlled transfection
efficiencies for the respective mutant proteins to enable
correct determination of VEGF production (Figure 9a, upper
panels and Figure 9b). Although myrAkt1 exhibited lowest
transfection efficiencies, low numbers of myrAkt1-expressing
cells remarkably represented the only conditions of signifi-
cantly elevated levels of VEGF (58±8pgml1) in transfected
wells compared to background production from mock-
treated cells (Figure 9c). Notably, calculated levels of VEGF
assuming a transfection efficiency of 100% (3052±
421pgml1) were in the range of EGF- (6032±682pgml1)
and cytokine- (3757±205pgml1) stimulated keratinocytes
that had been used as positive controls in this set of
experiments. In accordance, immunoprecipitation of wild-
type and mutated Flag-tagged Akt1 revealed that only the
VEGF-inducing myrAkt1 protein was phosphorylated at both
Ser473 and Thr308 residues (Figure 9c, lower panel).
Immunofluorescence stainings for myrAkt1 and phos-
phorylated 4E-BP1 in the same set of keratinocyte transfec-
tion experiments clearly demonstrated 4E-BP1
phosphorylation in the presence of myrAkt1 (Figure 10,
upper panel). To control the specificity of our immunofluor-
escence data, we added the mTOR inhibitor rapamycin to
inhibit the PI3K/Akt/mTOR pathway downstream of Akt1
with respect to 4E-BP1 phosphorylation (Figure 10, middle
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panel). Transfection of inactive Akt1-TASA again demon-
strated the specificity of the observed 4E-BP1 phosphoryla-
tion (Figure 10, lower panel).
Readjustment of insulin sensitivity in ob/ob mice restric-
tively mediates Akt1 phosphorylation and VEGF expression in
wound margin keratinocytes. Finally, we used a leptin
treatment of ob/ob mice to investigate whether the observed
in vitro changes in Akt1 phosphorylation and VEGF expres-
sion were also dependent on insulin sensitivity in vivo.
Therefore, mice were injected with recombinant leptin
during skin repair. Leptin treatment is well established to
resolve the obese and diabetic phenotype in ob/ob mice
(Frank et al., 2000; Goren et al., 2006, 2007). We confirmed
leptin effects in ob/ob mice by determination of blood
glucose levels (Figure 11a), serum insulin, and body weight
(Figure S3) in our animal experiment. Moreover, leptin
treatment has been shown to readjust the strongly disturbed
signaling from the insulin receptor in wound tissue of ob/ob
mice and to improve wound healing (Frank et al., 2000;
Goren et al., 2006).
Here we show that leptin-mediated resolution of insulin
resistance in ob/ob mice was paralleled by a significant
increase of the reduced wound VEGF protein observed in
acute 5-day wounds of diabetic animals (Figure 11b). More
important, only leptin treatment of ob/ob mice mediated a
strong colocalization of phosphorylated Akt1 (red color) and
VEGF protein (brown color) in wound keratinocytes of acute
wounds (day 5 post-wounding; Figure 11c, right panels). By
contrast, 5-day wound tissue of mock-treated ob/obmice was
characterized by the absence of abundant immunopositive
signals for both phosphorylated Akt1 and VEGF (Figure 11c,
left panels). These findings again argue for a functional
connection of insulin sensitivity, Akt1 activation, and VEGF
protein expression in wound keratinocytes.
Moreover, we observed a partial reappearance of Akt
phosphorylation also in 13-day late wound tissue of leptin-
treated ob/ob mice (Figure 11d). By contrast to conditions of
acute healing at day 5 post-injury (Figure 11b), we observed
highest levels of VEGF protein in chronic wound tissue of
mock-treated ob/ob mice (Figure 11e). Double staining of
wound tissues for phosphorylated Akt1 (red color) and VEGF
(brown color) again exhibited that wound keratinocytes of the
neoepidermis were responsible for the observed increase in
Akt phosphorylation (red) and the only low level production
of VEGF (brown) upon leptin treatment (Figure 11f, upper
right panel), as granulation tissues of those wounds showed a
complete absence of immunopositive signals for both
proteins (Figure 11f, lower right panel). Here it is noteworthy
that the weak signals for phosphorylated Akt in impaired
wounds of mock-treated ob/ob mice (Figure 11d), resulted
from a nearly complete absence of keratinocytes-expressing
phosphorylated Akt in atrophied neoepidermal structures that
failed to express high amounts of VEGF (Figure 11f, upper left
panel; Figure 11e). More important, the increased VEGF
protein levels in impaired 13-day wounds were produced
from infiltrating immune cells, most likely macrophages, in
an Akt-independent manner, as VEGF-positive cells in the
granulation tissue (Figure 11f, lower left panel, brown) did
not show any Akt1 phosphorylation (red).
DISCUSSION
At present there is growing evidence emphasizing a central
role of Akt in skin biology, evidencing roles of Akt in
keratinocyte biology. Activation of the PI3K/Akt signaling
pathway controls cell survival in differentiating keratinocytes
(Calautti et al., 2005; Pankow et al., 2006; Trash et al., 2006).
In addition, Akt1/Akt2 double-knockout mice displayed a
translucent skin with thinner individual skin layers as
compared to normal mice that could be attributed to a
reduced proliferation of the basal keratinocytes (Peng et al.,
2003). In agreement with the known role of Akt in
keratinocyte biology (Peng et al., 2003; Calautti et al.,
2005; Pankow et al., 2006; Trash et al., 2006), we
determined wound margin keratinocytes as the cellular
source of activated Akt also during skin repair. Peng et al.
(2003) noted Akt1 as the predominant Akt isoform in skin
siAkt1
+ Ins
siAkt1Scr
+ Ins
ScrCtrl
+ Ins
Ctrl
NS
**
**2,000
1,000
VE
G
F 
pr
ot
ei
n
(24
 ho
urs
) (
pg
 m
l–1
)
IB: β-actin
IB: total Akt
IB: Akt 2
IB: Akt 1
60 kDa
60 kDa
60 kDa
si
Ak
t1
 +
 In
s
si
Ak
t1
Sc
r +
 In
s
Ct
rl 
+ 
In
s
Ct
rl
Ct
rl
Ct
rl 
+ 
In
s
Sc
r
w/o
olfect +olfect
Figure 8. Specific abrogation of Akt1 by siRNA inhibits insulin-induced VEGF synthesis in keratinocytes. (a) Immunoblots demonstrating the efficiency
of Akt1 depletion in HaCaT by specific siRNA transfection. Cells were left without (w/o olfect) or with (þ olfect) transfection reagent oligofectamine in the
presence or absence of insulin or treated with a scrambled (scr) or Akt1-specific (siAkt1) siRNA in the presence or absence of insulin. Akt1 depletion was
controlled using a specific Akt1 (IB:Akt1), a specific Akt2 (IB:Akt2), or a total Akt (IB: total Akt) recognizing antibody. Loading of the immunoblot was controlled
using b-actin. (b) Cell culture supernatants of the respective nontransfected (ctrl), scr- and siAkt1 siRNA-treated HaCaT shown in (a) were analyzed for
VEGF protein release by ELISA after 24 hours of stimulation in the presence or absence of insulin. VEGF protein is expressed as pg per ml supernatant.
**, Po0.01; NS, not significant (unpaired Student’s t-test) as compared to nonstimulated conditions. Bars indicate the mean±SD obtained from
supernatants from three independent cell culture experiments (n¼ 3).
758 Journal of Investigative Dermatology (2009), Volume 129
I Goren et al.
Insulin drives Akt-mediated VEGF translation
tissue, and our experiments also demonstrated the Akt1 as the
predominant isoform in wound tissue and cultured HaCaT.
These observations were supported by data showing that
proliferating human primary keratinocytes expressed only the
Akt1 and 2 isoforms, from which only the targeted reduction
of Akt1, but not 2, was functionally connected to the
induction of keratinocyte cell death and the disruption of
an organized expression of differentiation markers in
organotypic skin cultures (Trash et al., 2006). These in vitro
findings, suggesting Akt1 to promote keratinocyte survival
during differentiation, might find their in vivo counterparts
during late skin repair. We observed activated Akt1 at mid- and
late stages of acute repair (days 7 and 13 post-wounding),
exactly when keratinocytes of the neoepithelial layer normally
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cease to proliferate and start to structure the neoepithelium by
subsequent differentiation (Martin, 1997; Singer and Clark,
1999). In good accordance, we found a marked increase in
Akt1 phosphorylation restrictively originating in keratinocytes
forming the robust neoepidermis following the leptin-mediated
resolution of the insulin-resistant phenotype in ob/ob mice.
Along the same line, diabetes-impaired wound conditions in
ob/ob mice revealed a loss of Akt1 activation during the
complete period of repair. Diabetes-impaired wounds in ob/ob
mice are characterized by severe defects in keratinocyte
proliferation and thus cell numbers (Frank et al., 2000).
Moreover, we have recently reported a severe insulin resistance
in wound tissue of ob/ob mice (Goren et al., 2006), which was
accompanied by an inhibition of insulin receptor downstream
signaling and a loss of GSK-3a/b phosphorylation. Thus, data
from this study close the gap, as we could now demonstrate
also the absence of activated Akt1 in impaired wound tissue
isolated from insulin-resistant ob/ob mice.
However, our study implicated additional roles of the
PI3K/Akt signaling pathway in keratinocytes. Here we
demonstrated that insulin, in addition to its functions as an
endocrine hormone-type mediator, directly acts on VEGF
gene expression during tissue regeneration. This observation
strongly indicates that the described insulin resistance in
wound tissue of diabetic ob/ob mice (Goren et al., 2006)
might not only interfere with resident glucose uptake and
metabolism. In addition, insulin and insulin-like growth
factor 1 have been shown to actively regulate VEGF
expression in several in vitro and in vivo model systems
such as cardiomyocytes, thyroid carcinoma cells, or retinal
epithelial cells (Treins et al., 2002; Jiang et al., 2003; Poulaki
et al., 2003; He et al., 2006). Notably, it was unique to
insulin here that VEGF production from keratinocytes could
be completely blocked by interference with PI3K/Akt signal-
ing. Inhibition of PI3K/Akt resulted in a delayed reduction of
4E-BP1 phosphorylation and a subsequent inhibition of VEGF
translation. The delayed appearance of dephosphorylated 4E-
BP1 protein upon wortmannin-mediated inhibition of insulin
action might result from early compensatory kinase activities,
especially that of p42/44 MAPK, which essentially contrib-
uted to insulin-stimulated VEGF release from keratinocytes
(this study). Thus, it is tempting to suggest a so far not
appreciated contribution of insulin to wound-derived VEGF
production in skin repair. This function might participate in
decreased levels of wound-derived VEGF associated with
wound healing disorders (Frank et al., 1995; Lauer et al.,
2000; Ka¨mpfer et al., 2001; Stallmeyer et al., 2001; Roth
et al., 2006; this study). The proposed previously unknown
function of insulin in tissue repair is further supported by our
observation that the resolution of insulin resistance in ob/ob
mice by leptin translated into a wound margin keratinocyte-
restricted reappearance of Akt1 phosphorylation and a
stringently colocalized VEGF protein in the cells.
Thus, our data are in clear accordance to Akt1-over-
expressing murine keratinocytes that displayed a tumorigenic
VEGF-mediated angiogenic switch that was clearly attributed
to an elevated translation of VEGF-specific mRNA and
increased phosphorylation of 4E-BP1 (Segrelles et al., 2004).
As also expression of matrix metalloproteinase-2 and -9
was coinduced by the similar posttranscriptional mechanism
(Segrelles et al., 2004) and as Akt1 overexpression mediated
an augmentation of also keratinocyte glucose uptake (I
Goren, unpublished data), one might speculate that cellular
consequences of insulin-driven Akt activation might not be
restricted to wound VEGF production. Along this line of
argumentation, two most recent papers connected epithelial
Akt activation to the process of skin carcinogenesis. As
mentioned above, Akt contributes to the tumor–stroma
relationship by enhancing angiogenic processes (Segrelles
et al., 2004). In addition, PI3K and subsequent Akt activation
have been described as early key events in chemically
induced models of skin tumorigenesis in mice (Segrelles
et al., 2002). In accordance, keratinocyte-directed over-
expression of Akt in transgenic mice mediated a generalized
hyperplasia of the interfollicular epidermis and the hair
follicles (Segrelles et al., 2007). Here it is reasonable to argue
that skin wounding appeared to initiate those functions of the
Akt1 protein that are connected to keratinocyte proliferative
and angiogenic responses to enable and drive a physiologic
response toward tissue regeneration.
In summary, we have shown that Akt1 was the predomi-
nant Akt isoform in skin repair. Our data on posttranscrip-
tional control of insulin-stimulated VEGF expression via Akt1
suggest a role of insulin in the control of keratinocyte
angiogenic potential in wound healing. As a severe insulin
resistance has been described in skin and wound tissue of
diabetic mice (Goren et al., 2006), which most probably also
blunts Akt activation after wounding (this study), loss of Akt-
mediated VEGF release from insulin-resistant wound margin
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keratinocytes might further aggravate the problem of reduced
angiogenesis in diabetes-impaired wounds.
MATERIALS AND METHODS
Animals
Female C57BL/6J (wild-type) and C57BL/6J-ob/ob mice (Mus
musculus) were obtained from Charles River (Sulzfeld, Germany).
At the age of 10 weeks, mice were caged individually, monitored for
body weight, and wounded as described below.
Treatment of mice
Murine recombinant leptin (Calbiochem, Bad Soden, Germany) was
injected intraperitoneally (2mg g1 body weight, one injection per
day, from 2 days before wounding until day 13 post-wounding). A
daily injection of phosphate-buffered saline (mock) was used as a
control.
Wounding of mice
Wounding of mice was performed as described previously (Frank
et al., 1999; Stallmeyer et al., 1999). Briefly, six full-thickness
wounds (5mm in diameter, 3–4mm apart) were made on the back of
each mouse by excising the skin and the underlying panniculus
carnosus. Skin biopsy specimens were obtained from the animals 1,
3, 5, 7, and 13 days after injury. Nonwounded back skin served as a
control. Wounds (n¼ 48) isolated from animals (n¼ 12) from three
independent animal experiments were used for RNA analysis. For
immunoblot analysis, wounds (n¼ 8) from four individual mice
(n¼ 4) were used. All animal experiments were performed according
to the guidelines and approval of the local Ethics Animal Review
Board.
Determination of blood glucose, insulin, and leptin levels
Blood glucose levels were determined using the Accutrend sensor
(Roche Biochemicals, Mannheim, Germany). Serum insulin and
leptin were analyzed by enzyme-linked immunosorbent assay
(Crystal Chemicals, Chicago, IL) as described by the manufacturer.
Cell culture
Quiescent human HaCaT (Boukamp et al., 1988) were stimulated
with EGF (10 ngml1), insulin (2 mgml1), or with a combination of
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were coincubated with antisera directed against murine phosphorylated Akt (Ser473) and murine VEGF. Sections were stained with the avidin–biotin–peroxidase
complex system and different chromogenic substrates. Immunopositive signals for phosphorylated Akt (Ser473; red) and for VEGF (brown) visualize the
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avidin–biotin–peroxidase complex system and different chromogenic substrates. Immunopositive signals for phosphorylated Akt (Ser473, red) and for VEGF
(brown) visualize the coexpression of activated Akt and VEGF proteins in wound tissue. Particularly double-stained cells (red: Akt and brown: VEGF) were
indicated by yellow arrows. Nuclei were counterstained with hematoxylin. gt, granulation tissue; ne, neoepidermis. Bar, 25mm.
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cytokines (2 nM IL-1b, 2 nM tumor necrosis factor-a, 100Uml1
interferon (IFN)-g) in the presence or absence of 200 nM wortmannin,
10 mM U0126, 5 mM SB203580, or 50 ngml1 rapamycin for the
indicated periods of time. EGF, IFN-g, and insulin were purchased
from Roche Biochemicals and IL-1bor tumor necrosis factor-a was
from Peprotec (Hanau, Germany). Wortmannin and SB203580 were
obtained from Calbiochem (Darmstadt, Germany) and U0126 was
from Alexis (San Diego, USA). Rapamycin (50 ngml1) was also
used in the transfection studies and obtained from Calbiochem
(Darmstadt, Germany).
Silencing of Akt1 expression by siRNA
HaCaT (2 105) were grown in six-well plates to reach 40–60%
confluency. Cells were subsequently transfected twice with siRNA
(50 nM final concentration) using oligofectamine (Invitrogen, Karls-
ruhe, Germany) and OptiMEM (Invitrogen) as described by the
manufacturer. The Akt1-specific siRNA was purchased from Applied
Biosystems (Darmstadt, Germany).
RNA isolation and RNase protection analysis
RNA isolation and RNase protection assays were carried out as
described previously (Chomczynski and Sacchi, 1987; Frank et al.,
1999). The murine cDNA corresponded to nucleotides 1598–1917
(for Akt1, X65687), 1437–1701 (for Akt2, U22445), 1451–1710 (for
Akt3, AF124142), 139–585 (for VEGF, S38083), 3998–4183 (for
loricrin, U09189.1), or 163–317 (for GAPDH, NM002046) of the
published sequences. The human cDNA corresponded to 339–498
(for VEGF, (Weindel et al., 1992) or 961–1070 (for GAPDH,
M33197) of the published sequences. Total cellular RNA from
keratinocytes of three independent cell culture experiments (n¼ 3)
was analyzed by RNase protection assay.
Preparation of protein lysates and immunoblot analysis
Murine skin and HaCaT culture samples were homogenized as
described (Ka¨mpfer et al., 1999; Goren et al., 2006). Cytoplasmic
and nuclear fractions were generated according to a published
protocol (Schreiber et al., 1989). Protein concentrations were
determined using the BCA Protein Assay Kit (Pierce Inc., Rockford,
IL, USA). Total protein lysate (20–50 mg) was separated using SDS-gel
electrophoresis, and specific proteins were detected using antisera
directed against Akt1 (Biomol, Hamburg, Germany and Epitomics,
Hamburg, Germany), total Akt or Akt2, Akt3, phosphorylated Akt
(Ser473), phosphorylated Akt (Thr308), phospho-GSK-3a/b (Ser21/9),
phospho-eucaryotic initiation factor 4E-BP1 (Thr37/46), total 4E-BP1
(Cell Signaling, New England Biolabs, Frankfurt, Germany), Flag
fusion proteins (Sigma, Taufkirchen, Germany), nucleolin and
insulin receptor-b (Santa Cruz, Heidelberg, Germany), respectively.
A secondary antibody coupled to horseradish peroxidase and the
ECL detection system was used to visualize the proteins of interest.
Phenylmethylsulfonyl fluoride, aprotinin, NaF, Na2VO4, and dithio-
threitol were from Sigma. Ocadaic acid and leupeptin were from
BioTrend (Ko¨ln, Germany) and the ECL detection system was
obtained from Amersham (Freiburg, Germany).
Separation of epidermis and dermis layer of mouse tail skin
Mouse tail skin was incubated for 30minutes at 37 1C in a solution of 2M
NaBr. The epidermis was separated from the underlying dermis, imme-
diately frozen in liquid nitrogen and used for subsequent analyses.
Immunoprecipitation
Total wound or cell culture lysate (200 mg) was incubated overnight
with the respective Akt1- (Epitomics and Biomol), Akt2-, Akt3- (Cell
Signaling), or Flag- (Sigma) specific antibodies according to
instructions of the manufacturer. Immunoprecipitates were isolated
using protein G sepharose (Sigma). Flag-tagged Akt1 was immuno-
precipitated using an anti-Flag M2 affinity gel (Sigma) in 500 ml of
Flag buffer (25mM Tris-Cl, pH 7.4, 150mM NaCl, 1mM CaCl2, 1%
Triton X-100). Protein G sepharose- and Flag-bound precipitates
were washed in TBST (150mM NaCl, 10mM Tris-Cl, pH 8.0, 0,05%
Tween 20) and protein was eluted using Laemmli buffer. Triton
X-100 and Tween 20 were obtained from Sigma.
Enzyme-linked immunosorbent assay
Quantification of human or mouse VEGF protein was performed
using the human or mouse VEGF Quantikine ELISA kit (R&D
systems, Wiesbaden, Germany). Supernatants from three indepen-
dent cell culture experiments (n¼ 3) were analyzed. Phosphorylated
Akt (S473) protein was quantified in wound lysates using the Akt
(pS473) immunoassay kit (Biosource, Nivelles, Belgium).
Immunohistochemistry
Mice were wounded as described above. Animals were killed at
days 3 and 5 after injury. Complete wounds were isolated from the
back, bisected, and frozen in tissue freezing medium. Frozen
sections (6 mm) were subsequently analyzed using immunohisto-
chemistry as described (Stallmeyer et al., 1999). Antisera against
phosphorylated Akt (Ser473), phosphorylated Akt (Thr308), phos-
pho-GSK-3a/b (Ser21/9; Cell Signaling), or VEGF (Santa Cruz) were
used for immunodetection.
Immunocytochemistry
HaCaT keratinocytes were grown on glass slides until they reached
50% confluency. Cells were fixed using methanol/EDTA (0.02%
w/v) for 15minutes at 20 1C. Immunostaining was performed using
an anti-Flag antibody (1:200 dilution; Sigma) according to the ABC
peroxidase staining kit from Santa Cruz.
Immunofluorescence
HaCaT keratinocytes were grown on glass slides and stimulated with
insulin (2 mgml1) as described above. Control and stimulated cells
were subsequently fixed using methanol/EDTA (0.02% w/v) or
paraformaldehyde (2% w/v) for 15minutes at 20 1C or room
temperature, respectively. Fixed cells were blocked with 5% goat
serum diluted in phosphate-buffered saline/Triton (0.1% w/v).
Antisera against Flag fusion proteins (Sigma) and phosphorylated
4E-BP1 (Thr37/46; Cell Signaling) were incubated for 1 hour at room
temperature. The fluorescence-coupled secondary antibodies Alexa
Fluor 488 (Molecular Probes, Leiden, The Netherlands) or Cy3
(Dianova, Hamburg, Germany) were diluted 1:250 in 5% goat
serum/phosphate-buffered saline and incubated in the dark for
30minutes. Nuclei were counterstained using 40,6-diamidino-2-
phenylindole (Sigma).
Generation of mutated and Akt1-Flag fusion constructs
A full-length human Akt1 cDNA was amplified from total HaCaT
keratinocyte cDNA using plaque-forming unit polymerase (Promega,
Mannheim, Germany) and 50-GATAGAATTCGGGCACCATGAGC
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GACG-30 and 50-CTATGGATCCGGCCGTGCTGCTGGC-30 as pri-
mers. Amplicons were cloned into EcoRI/BamHI sites of pCMV-Flag
N3 (kindly provided by M Bachmann) (Bachmann et al., 2004). The
pCMV-NE-Akt1-Flag was used as a template for subsequent cloning
strategies. Mutation of Akt1 Thr308 and Ser473 residues was
performed using the pCMV-NE-Akt1-Flag vector as a template, the
QuickChange Site-Directed Mutagenesis Kit (Stratagene, Heidel-
berg, Germany) and the following primers: 50-GGTGCCACCAT
GAAGGCCTTTTGCGGCACAC-30 (for the Thr308 to Ala mutation,
Akt1-T308A) and 50-CCCACTTCCCCCAGTTCGCGTACTCGGCCA
GCAGCACG-30 (for the Ser473 to Ala mutation, Akt1-S473A). The
Ser473 and Thr308 to Ala Akt1 double mutant was generated by
cloning an EcoRI/HindIII fragment of pCMV-NE-Akt1-T308A into
pCMV-NE-Akt1-S473A from which the EcoRI and HindIII was
removed (pCMV-NE-Akt1-TASA). A myristoylated form of Akt1
was cloned by PCR using pCMV-NE-Akt1-Flag as template and 50-
AGATCTCGAGCCACCATGGGGAGTAGCAAGAGCAAGCCTAAG
GACCCCAGCCAGCGCGCTAGCGACGTGGCTATTGTG-30 (harbor-
ing the v-src myristoylation signal) and 50-CCACATCCTGCGGCC-30
as primers. Amplicons were digested with NotI and subcloned into
the NheI/NotI site of pCMV-Akt1-Flag-N3 (myr-Akt1).
Transfection experiments
HEK293 and HaCaT cells were transiently transfected with FuGene
transfection reagent (Roche Biochemicals) and the appropriate
plasmid DNA according to the instructions of the manufacturer.
Statistical analysis
Data are shown as means±SD. Data analysis was carried out using
the unpaired Student’s t-test with raw data. Statistical comparison
between more than two groups was carried out by analysis of
variance (Dunnett’s method).
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Figure S1. Localization of Akt in regenerating skin.
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